Business Context and Reporting Period
This Form 6-K filing by Farmmi, Inc. covers the month of September 2021. The company, a Cayman Islands corporation, reported significant strategic shifts including the establishment of new subsidiaries to enter the healthcare industry, a divestiture of its agriculture food business, and acquisitions to expand its forest-related operations.
Key Financial Metrics
The filing does not provide specific financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics for the period. The document focuses on corporate actions and transaction values rather than operational financial performance.
Material Changes and Transactions
- New Subsidiaries: Established four new entities in September 2021 to expand into the healthcare sector: Zhejiang Yitang Medical Service Co., Ltd., Zhejiang Yiting Medical Technology Co., Ltd., Farmmi (Hangzhou) Health Development Co., Ltd., and Zhejiang Farmmi Healthcare Technology Co., Ltd.
- Divestiture: Sold 100% equity of Zhejiang Forest Food Co., Ltd. to an unrelated party, Lishui Zhongjun Technology Co., Ltd., for RMB 18,200,000. This decision was driven by challenges in the agriculture food business.
- Acquisitions:
- Acquired 100% of Jiangxi Xiangbo Agriculture and Forestry Development Co., Ltd. for RMB 70,000,000 to expand forest-related business.
- Acquired 100% of Guoning Zhonghao (Ningbo) Trade Co., Ltd. for RMB 5,000; the target had nominal operations at the time of acquisition.
- Internal Restructuring: Transferred approximately 77% of the shares of Lishui Farmmi E-Commerce Co., Ltd. from Zhejiang Forest to Farmmi Agricultural for no consideration prior to the divestiture of Zhejiang Forest.
Guidance, Outlook, and Management Commentary
CEO Yefang Zhang issued a letter to shareholders on September 29, 2021, outlining strategic plans for future development and market expansion through acquisition. Management indicated a strategic pivot away from the agriculture food business due to operational challenges and a deliberate move to enter the healthcare industry and expand forest-related operations. The Board of Directors approved all transactions, deeming the prices fair and in the best interests of shareholders.
Investor Verification Checklist
- Verify the integration progress and regulatory status of the four new healthcare subsidiaries.
- Confirm the completion of the RMB 70 million acquisition of Jiangxi Xiangbo and its impact on future revenue streams.
- Assess the financial impact of the divestiture of Zhejiang Forest and the removal of the agriculture food business from the consolidated results.
- Review the full text of the CEO's letter (Exhibit 99.1) for detailed strategic roadmaps not fully elaborated in this summary.